WallStSmart

The Ensign Group Inc (ENSG)vsSandisk Corp (SNDK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sandisk Corp generates 77% more annual revenue ($8.93B vs $5.06B). ENSG leads profitability with a 6.8% profit margin vs -11.7%. ENSG earns a higher WallStSmart Score of 57/100 (C).

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.7Quality: 5.8
Piotroski: 5/9Altman Z: 2.34

SNDK

Hold

49

out of 100

Grade: D+

Growth: 7.3Profit: 5.0Value: 5.0Quality: 8.0
Piotroski: 4/9Altman Z: 1.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGUndervalued (+0.4%)

Margin of Safety

+0.4%

Fair Value

$212.73

Current Price

$200.08

$12.65 discount

UndervaluedFair: $212.73Overvalued

Intrinsic value data unavailable for SNDK.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

SNDK5 strengths · Avg: 9.8/10
Operating MarginProfitability
35.5%10/10

Strong operational efficiency at 35.5%

Revenue GrowthGrowth
61.2%10/10

Revenue surging 61.2% year-over-year

EPS GrowthGrowth
618.0%10/10

Earnings expanding 618.0% YoY

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Market CapQuality
$104.75B9/10

Large-cap with strong market position

Areas to Watch

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.874/10

Expensive relative to growth rate

P/E RatioValuation
35.8x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

SNDK4 concerns · Avg: 2.8/10
Price/BookValuation
10.3x4/10

Trading at 10.3x book value

Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

Return on EquityProfitability
-9.4%2/10

ROE of -9.4% — below average capital efficiency

Profit MarginProfitability
-11.7%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bull Case : SNDK

The strongest argument for SNDK centers on Operating Margin, Revenue Growth, EPS Growth. Revenue growth of 61.2% demonstrates continued momentum.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Bear Case : SNDK

The primary concerns for SNDK are Price/Book, Altman Z-Score, Return on Equity.

Key Dynamics to Monitor

ENSG profiles as a growth stock while SNDK is a hypergrowth play — different risk/reward profiles.

SNDK is growing revenue faster at 61.2% — sustainability is the question.

SNDK generates stronger free cash flow (980M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ENSG scores higher overall (57/100 vs 49/100) and 20.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Sandisk Corp

TECHNOLOGY · COMPUTER HARDWARE · USA

Sandisk Corporation (Ticker: SNDK) is a U.S.-based technology company that develops, manufactures, and sells data storage products and solutions built on NAND flash memory technology, including solid-state drives (SSDs), embedded storage, memory cards, and USB flash drives for consumer, enterprise, and cloud computing markets.

Visit Website →

Want to dig deeper into these stocks?